Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer
Archives of Pathology and Laboratory Medicine
Saved in:
Main Authors: | Salto-Tellez, M., Yau, E.X., Yan, B., Fox, S.B. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Editorial |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/108627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A study of HER2 gene amplification and protein expression in gastric cancer
by: Yan, B., et al.
Published: (2014) -
Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours.
by: Tai, L.K., et al.
Published: (2016) -
Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer
by: Zhang, D.-H., et al.
Published: (2012) -
Detection of HER2/neu gene amplification in archival paraffin-embedded breast cancer tissues by fluorescence in situ hybridization
by: Selvarajan, S., et al.
Published: (2015) -
Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples
by: Yan, B., et al.
Published: (2014)